CONMED Corporation (NASDAQ:CNMD) has been issued a 2 rating by the sell-side brokerage firms covering the stock. Basing the rating on a simplified scale where 1 represents a Buy and 5 represents a Sell, this is the average rating based on the 6 firms polled by Zacks Research. To determine the direction the stock sentiment is headed, it’s noted that the stock had a rating of 2 three months ago.
The sell-side brokers covering the equity also have issued projected stock price objectives on the company. The one year projections range from a high of $65 to the low of $51. The mean price target of all analysts taken into consideration by Zacks is $59.
Earnings at a Glance
Near term, Wall Street brokerage analysts are expecting CONMED Corporation (NASDAQ:CNMD) to report earnings of $0.43 per share for the fiscal quarter ending on 2015-06-30. This is the calculated earnings per share estimate from the 6 polled by Zacks. In taking a look further ahead three to five years, analysts have a long-term growth EPS estimate of $15. This number is the best estimate for sales and earnings over that time frame.
Stock holders will be watching when CONMED Corporation reports their next earnings results on 2015-07-22. Most recently the firm announced earnings per share of $0.42 for the quarter which ended on 2015-03-31. Compared to analyst expectations just before the announcement, the actual results were $0.01 away from that number, or a surprise factor of 2.44%.
CONMED Corporation (CONMED) is a medical technology company/ The Company emphasizes on surgical devices and equipment for minimally invasive procedures and monitoring. The Company’s products are used by surgeons and physicians in a range of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The Company operates in five segments: CONMED Endoscopic Technologies, CONMED Endosurgery, CONMED Electrosurgery, CONMED Linvatec and CONMED Patient Care. The Company offers a range of devices and products for uses in arthroscopic surgery. The Company’s powered instruments product line includes the MPower battery system. The Company’s patient care product line includes a line of vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, electrocardiogram (ECG) electrodes and cables, cardiac defibrillation and pacing pads and blood pressure cuffs.
